Coronavirus vaccine update: MHRA responds to blood clot fears over Oxford-AstraZeneca jab


The decision to temporarily pause the rollout of the AstraZeneca/Oxford COVID-19 vaccine in Denmark due to reports of blood clots has sparked widespread panic. However, as of yet, there is no proven link between the two. In response to the news, Dr Phil Bryan, Medicines and Healthcare products Regulatory Agency (MRHA), Vaccines Safety Lead said: “Vaccine safety is of paramount importance and we continually monitor the safety of vaccines to ensure that the benefits outweigh any potential risks. It has not been confirmed that the report of a blood clot, in Denmark, was caused by the COVID-19 Vaccine AstraZeneca.”

“It has not been confirmed that the report of a blood clot, in Denmark, was caused by the COVID-19 Vaccine AstraZeneca.

“The Danish authorities’ action to temporarily suspend use of the vaccine is precautionary whilst they investigate.

“Blood clots can occur naturally and are not uncommon. More than 11 million doses of the COVID-19 Vaccine AstraZeneca vaccine have now been administered across the UK.

“Reports of blood clots received so far are not greater than the number that would have occurred naturally in the vaccinated population.

READ MORE: AstraZeneca vaccine suspended: Why has Denmark stopped using the Oxford Covid jab?

Dr Bryan added: “The safety of the public will always come first. We are keeping this issue under close review but available evidence does not confirm that the vaccine is the cause.

“People should still go and get their COVID-19 vaccine when asked to do so.”

The MHRA encourages anyone to report any suspicion or concern they have beyond the known, mild side effects on the Coronavirus Yellow Card site.

Despite pausing the rollout, Denmark’s National Board of Health has also reassured the general public.

Statins: What is the best time to take statins? [TIPS]
Back pain: Eight signs it’s serious [INSIGHT]
Diabetes type 2: Symptoms in feet [ADVICE]

“There is good evidence that the vaccine is both safe and effective,” said Søren Brostrøm, director of Denmark’s National Board of Health.

But he added: “We and the Danish Medicines Agency have to react to reports of possible serious side effects.”

Denmark’s health authorities added: “At present, it cannot be concluded whether there is a link between the vaccine and the blood clots.”

The European country is not alone in taking reactionary measures to the reports.



Leave a comment